Showing 1 to 6 of 6 results


Backlash Against Kennedy's Autism Comments
HHS Secretary Robert F. Kennedy Jr.'s comments linking autism to environmental factors and portraying autistic individuals negatively sparked outrage from parents and autism advocates, who emphasize the diversity of abilities and potential within the autism spectrum, and the rising autism diagnoses ...
Backlash Against Kennedy's Autism Comments
HHS Secretary Robert F. Kennedy Jr.'s comments linking autism to environmental factors and portraying autistic individuals negatively sparked outrage from parents and autism advocates, who emphasize the diversity of abilities and potential within the autism spectrum, and the rising autism diagnoses ...
Progress
48% Bias Score


Naples Conference Addresses Challenges in Diagnosing Level 1 Autism Spectrum Disorder
An autism conference in Naples, Italy, focuses on diagnostic challenges of Level 1 Autism Spectrum Disorder (formerly Asperger's Syndrome), highlighting the impact of symptom masking and the need for early detection and intervention. Experts are discussing improved diagnostic approaches and therapeu...
Naples Conference Addresses Challenges in Diagnosing Level 1 Autism Spectrum Disorder
An autism conference in Naples, Italy, focuses on diagnostic challenges of Level 1 Autism Spectrum Disorder (formerly Asperger's Syndrome), highlighting the impact of symptom masking and the need for early detection and intervention. Experts are discussing improved diagnostic approaches and therapeu...
Progress
36% Bias Score


Defense in Idaho Murders Case Cites Autism to Prevent Death Penalty
Bryan Kohberger's defense team filed a motion Monday to prevent the death penalty in the Idaho quadruple homicide case, citing autism spectrum disorder; the full motion is under seal, and the trial is set for August.
Defense in Idaho Murders Case Cites Autism to Prevent Death Penalty
Bryan Kohberger's defense team filed a motion Monday to prevent the death penalty in the Idaho quadruple homicide case, citing autism spectrum disorder; the full motion is under seal, and the trial is set for August.
Progress
28% Bias Score

US Autism Diagnoses Rise to One in 31 Among 8-Year-Olds
The CDC reports a rise in autism diagnoses among 8-year-olds in the US from one in 36 in 2020 to one in 31 in 2022, largely due to improved awareness, broader diagnostic criteria, and increased access to services; however, racial disparities persist and further research is needed.

US Autism Diagnoses Rise to One in 31 Among 8-Year-Olds
The CDC reports a rise in autism diagnoses among 8-year-olds in the US from one in 36 in 2020 to one in 31 in 2022, largely due to improved awareness, broader diagnostic criteria, and increased access to services; however, racial disparities persist and further research is needed.
Progress
48% Bias Score

Kohberger's Autism Diagnosis Prompts Death Penalty Challenge
Bryan Kohberger, the suspect in the November 2022 Idaho murders of four University of Idaho students, has been diagnosed with autism spectrum disorder (ASD), prompting his defense team to argue against the death penalty due to his condition's potential impact on culpability and legal proceedings.

Kohberger's Autism Diagnosis Prompts Death Penalty Challenge
Bryan Kohberger, the suspect in the November 2022 Idaho murders of four University of Idaho students, has been diagnosed with autism spectrum disorder (ASD), prompting his defense team to argue against the death penalty due to his condition's potential impact on culpability and legal proceedings.
Progress
20% Bias Score

Full-Spectrum Cannabis Drug Shows Promise in Autism Treatment
Ajna BioSciences, in collaboration with Charlotte's Web and British American Tobacco, is developing AJA001, a full-spectrum hemp-derived cannabinoid drug for autism spectrum disorder (ASD), which successfully completed Phase 1 trials demonstrating safety and efficacy, and plans to launch Phase 2 tri...

Full-Spectrum Cannabis Drug Shows Promise in Autism Treatment
Ajna BioSciences, in collaboration with Charlotte's Web and British American Tobacco, is developing AJA001, a full-spectrum hemp-derived cannabinoid drug for autism spectrum disorder (ASD), which successfully completed Phase 1 trials demonstrating safety and efficacy, and plans to launch Phase 2 tri...
Progress
44% Bias Score
Showing 1 to 6 of 6 results